It contains trials that are in NCI's list of cancer trials as well as trials sponsored by pharmaceutical or biotech companies that may not be on NCI's list. Cancer trials may offer patients access to treatment options that would otherwise be unavailable to them. This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. For help understanding the protocol summary, call, email, or chat with one of our cancer information specialists. Keep in mind that the search results do not replace advice from your doctor. He or she may also be able to search for a trial for you, provide information, and answer questions to help you decide about joining a clinical trial. Tax-ID: 73-1386920, A randomized, phase II study of nivolumab after combined modality therapy (CMT) in high-risk anal cancer (EA2165), S1815: A phase III randomized trial of gemcitabine, cisplatin and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers, An open-label, randomized, phase 2 trial of SAR439859, versus endocrine monotherapy as per physician's choice in premenopausal and postmenopausal patients with estrogen receptor-positive, HER2-negative locally advanced or metastatic breast cancer with prior exposure to hormonal therapies (ACT16105), Merck KEYNOTE-756: A randomized, double-blind, phase 3 study of pembrolizumab versus placebo in combination with neoadjuvant chemotherapy and adjuvant endocrine therapy for the treatment of high-risk, early-stage estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, NRG-BR002: A phase IIR/III trial of standard-of-care therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical ablation for newly oligometastatic breast cancer, DS8201-A-U303 (DESTINY-Breast04): A Phase 3, multicenter, randomized, open-label, active-controlled trial of DS-8201a, an anti-HER2-antibody drug conjugate (ADC), versus treatment of physician’s choice for HER2-low, unresectable and/or metastatic breast cancer subjects, NRG-BR003: A randomized phase III trial of adjuvant therapy comparing doxorubicin plus cyclophosphamide followed by weekly paclitaxel with or without carboplatin for node-positive or high-risk node-negative triple-negative invasive breast cancer, Testing MK-3475 (pembrolizumab) as adjuvant therapy for triple receptor-negative breast cancer (S1418), Novartis CLEE011012301C: A phase 3, multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as an adjuvant treatment in patients with hormone receptor-positive, HER2-negative early breast cancer (new adjuvant trial with ribociclib [LEE011]: NATALEE), NRG-BR004: A randomized, double-blind, phase III trial of paclitaxel/trastuzumab/pertuzumab with atezolizumab or placebo in first-line HER2-positive metastatic breast cancer. Trying to find a clinical trial for any type of blood cancer can sometimes feel overwhelming, but connecting to clinical trials is now easier than ever.Whether it’s your first time looking, you’ve looked before, or even participated in a trial already, our new clinical trial finder … You can also always call 1-800-4-CANCER (1-800-422-6237) to speak with an NCI cancer information specialist in English or Spanish. This includes enrolling qualified patients in carefully selected clinical trials … Around 32% of 80,000 brain tumors diagnosed per year in the U.S. turn out to be cancerous. A clinical trial is a research study that is conducted on people to find out how a new treatment works on a disease in a safe, controlled environment. Our Clinical Trial Finder gives you access to the most comprehensive and up-to-date database of pancreatic cancer clinical trials … Not all protocol summaries provide this information. Learn more about specific Lustgarten Foundation and Stand Up To Cancer-supported clinical trials by utilizing our clinical trial finder below. Our doctors may recommend that cancer patients enroll in cancer … CenterWatch. Refer to the form during your search for a clinical trial. A protocol summary should explain the goal of the trial and describe which treatments will be tested. The websites of these organizations may not be updated regularly. What are Clinical Trials? Doctors use clinical trials to develop new treatments for serious diseases such as cancer. You will also need to ask whether the sponsoring organization will pay for some or all of your travel costs. Cancer Treatment Centers of America® (CTCA) is committed to providing new and innovative treatments for our cancer patients whenever possible. … Keep in mind that the search … Getting started with the Colorectal Cancer Alliance Clinical Trial Finder is easy! The more information you can gather, the easier it will be to find a clinical trial to fit your situation. This includes enrolling qualified patients in carefully selected clinical trials for cancer. Keep the following points in mind about clinical trial listing services: Cancer advocacy groups provide education, support, financial assistance, and advocacy to help patients and families who are dealing with cancer, its treatment, and survivorship. Please note that if you select one of these websites, you will leave Cancer.Net. Because of the many types of sponsors, no single list contains every clinical trial. Use the tool below to find a CTCA ® clinical trial for your cancer type. You may have to contact a cancer center clinical trials office to get more information about the trials that interest you. … These organizations generally do not sponsor or take part in clinical trials. The GENERATE Study is also open across the United States for people who have a close relative with pancreatic cancer… Find a clinical trial. Home About Cancer Find a clinical trial. Many of these websites have lists of clinical trials or refer you to the websites of organizations that match patients to trials. Do the details of your cancer diagnosis and your current overall state of health match the trial's eligibility criteria? To find trials, search the websites of advocacy groups for specific types of cancer. ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine. Some will have information about clinical trials that are enrolling patients. To make a final decision, you will want to know the potential risks and benefits of all treatment options available to you. Often, your doctor may know about a clinical trial that could be a good option for you. Answering a simple series of questions allows us to find relevant trials that fit your needs. Because many of these groups focus on a specific type of cancer, they can help you find trials for your type of cancer. To request their help, complete the online form. Clinical trials are a key testing ground for determining the effectiveness and safety of new treatments and drugs for cancer and other diseases. These organizations recognize that clinical trials are important to improving cancer care. Once you have completed the Cancer Details Checklist and found some trials that interest you, you should now: Helpful Tip: Don't worry if you can't answer all of the questions below just yet.